Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Why maximum tolerated dose?

Stampfer HG, Gabb GM, Dimmitt SB.

Br J Clin Pharmacol. 2019 Jun 20. doi: 10.1111/bcp.14032. [Epub ahead of print] Review.

PMID:
31219196
2.

High and variable population prevalence of HLA-B*56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms.

Somogyi AA, Barratt DT, Phillips EJ, Moore K, Ilyas F, Gabb GM.

Br J Clin Pharmacol. 2019 Sep;85(9):2163-2169. doi: 10.1111/bcp.14025. Epub 2019 Jul 19.

PMID:
31206740
3.

Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.

Caughey GE, Gabb GM, Ronson S, Ward M, Beukelman T, Hill CL, Limaye V.

JAMA Intern Med. 2018 Sep 1;178(9):1224-1229. doi: 10.1001/jamainternmed.2018.2859. Erratum in: JAMA Intern Med. 2018 Dec 1;178(12):1732.

4.

Review article: Environmental heatstroke and long-term clinical neurological outcomes: A literature review of case reports and case series 2000-2016.

Lawton EM, Pearce H, Gabb GM.

Emerg Med Australas. 2019 Apr;31(2):163-173. doi: 10.1111/1742-6723.12990. Epub 2018 May 31. Review.

PMID:
29851280
5.

SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.

Meyer EJ, Gabb G, Jesudason D.

Diabetes Care. 2018 Apr;41(4):e47-e49. doi: 10.2337/dc17-1721. Epub 2018 Feb 13. No abstract available.

PMID:
29440112
6.

Time to resurrect hypertension.

Gabb GM.

Intern Med J. 2017 Dec;47(12):1466. doi: 10.1111/imj.13630. No abstract available.

PMID:
29224208
7.

A personalised or procrustean approach to treating hypertension?

Gabb GM, Mol PGM, Arnolda LF.

Lancet. 2017 Jul 1;390(10089):26-27. doi: 10.1016/S0140-6736(17)31597-0. No abstract available.

PMID:
28677555
8.

Great big meta-analysis of everything: follow-up complete and known, the ultimate paean.

Gabb GM.

Intern Med J. 2017 Jun;47(6):705-707. doi: 10.1111/imj.13439. Review.

PMID:
28580743
9.

Geographic location as a modifiable cardiac risk factor.

Gabb G, Arnolda L.

CMAJ. 2017 Apr 3;189(13):E482-E483. doi: 10.1503/cmaj.170116. No abstract available.

10.

Guideline for the diagnosis and management of hypertension in adults - 2016.

Gabb GM, Mangoni AA, Arnolda L.

Med J Aust. 2017 Feb 20;206(3):141. No abstract available.

PMID:
28208049
11.

Guideline for the diagnosis and management of hypertension in adults - 2016.

Gabb GM, Mangoni AA, Anderson CS, Cowley D, Dowden JS, Golledge J, Hankey GJ, Howes FS, Leckie L, Perkovic V, Schlaich M, Zwar NA, Medley TL, Arnolda L.

Med J Aust. 2016 Jul 18;205(2):85-9.

PMID:
27456450
12.

Limitations of meta-analysis, drug safety remain uncertain.

Gabb GM, Ronson S.

Intern Med J. 2016 May;46(5):640-1. doi: 10.1111/imj.12893. No abstract available.

PMID:
27170250
13.

Scurvy not rare.

Gabb G, Gabb B.

Aust Fam Physician. 2015 Jul;44(7):438-40. No abstract available.

PMID:
26922826
14.

Therapeutic drug safety for Indigenous Australians: how do we close the gap?

Thynne T, Gabb GM.

Med J Aust. 2016 Jan 18;204(1):16-7. No abstract available.

PMID:
26763808
15.

Data informs debate.

Gabb G, Vitry A, Thynne T.

Aust Prescr. 2015 Aug;38(4):113-4. Epub 2015 Aug 3. No abstract available.

16.

Multicentre audit of ACE-inhibitor associated angioedema (MAAAA).

Gandhi J, Jones R, Teubner D, Gabb G.

Aust Fam Physician. 2015 Aug;44(8):579-83.

17.

Drug safety in Aboriginal Australians: three cases of angiotensin-converting enzyme inhibitor angioedema.

Mahajan H, Thynne T, Gabb GM, Poh EW.

Intern Med J. 2015 Feb;45(2):231-3. doi: 10.1111/imj.12659. No abstract available.

PMID:
25650541
18.

Professionalism, patient-centred care and revalidation.

Gabb G.

Intern Med J. 2014 Mar;44(3):312. doi: 10.1111/imj.12355. No abstract available.

PMID:
24621292
19.

Lump in the throat - a case study.

Gabb G, Andrew N.

Aust Fam Physician. 2013 Dec;42(12):863-6.

20.

Serious statin-associated myotoxicity and rhabdomyolysis in Aboriginal and Torres Strait Islanders: a case series.

Gabb GM, Vitry A, Condon J, Limaye V, Alhami G.

Intern Med J. 2013 Sep;43(9):987-92. doi: 10.1111/imj.12196. Erratum in: Intern Med J. 2016 May;46(5):642.

PMID:
23692462
21.

Incretin-based therapies and a potential drug interaction.

Gabb GM, Smith W.

Intern Med J. 2011 Dec;41(12):848. No abstract available.

PMID:
22737698
22.

ACEI associated angioedema - a case study and review.

Andrew N, Gabb G, Del Fante M.

Aust Fam Physician. 2011 Dec;40(12):985-8. Review.

23.

Robust, reliable drug safety information.

Gabb G.

Am J Med. 2011 Apr;124(4):e5; author reply e7. doi: 10.1016/j.amjmed.2010.11.018. No abstract available.

PMID:
21435411
24.

Oral hypoglycaemics.

Gabb G.

Aust Fam Physician. 2010 Nov;39(11):812. No abstract available.

PMID:
21391324
25.

The first documented case of Candida dubliniensis leptomeningeal disease in an immunocompetent host.

Andrew NH, Ruberu RP, Gabb G.

BMJ Case Rep. 2011 Aug 4;2011. pii: bcr0620114384. doi: 10.1136/bcr.06.2011.4384.

26.

Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.

Wing LM, Arnolda LF, Harvey PJ, Upton J, Molloy D, Gabb GM, Bune AJ, Chalmers JP.

Blood Press. 1998 Nov;7(5-6):299-307.

PMID:
10321443
27.

Striking a balance in drug information--the Australian Medicines Handbook.

Gabb G.

Aust N Z J Med. 1998 Oct;28(5):675. No abstract available.

PMID:
9847968
28.

Epidemiological study of angioedema and ACE inhibitors.

Gabb GM, Ryan P, Wing LM, Hutchinson KA.

Aust N Z J Med. 1996 Dec;26(6):777-82.

PMID:
9028507
29.

Angioedema of the intestine.

Gabb GM.

N Engl J Med. 1996 Nov 14;335(20):1534-5; author reply 1535. No abstract available.

PMID:
8927095
30.

Perhexiline--stable plasma concentrations with formulation change.

Siebert WJ, Gabb GM, Wing LM.

Aust N Z J Med. 1996 Oct;26(5):707-8. No abstract available.

PMID:
8958370
31.

Fatal outcome of interaction between warfarin and a non-steroidal anti-inflammatory drug.

Gabb GM.

Med J Aust. 1996 Jun 3;164(11):700-1. No abstract available.

PMID:
8657040
32.

Bronchial responsiveness to exercise after human cardiopulmonary transplantation.

Glanville AR, Gabb GM, Theodore J, Robin ED.

Chest. 1989 Aug;96(2):281-6.

PMID:
2666042
33.

Hyperbaric oxygen. A therapy in search of diseases.

Gabb G, Robin ED.

Chest. 1987 Dec;92(6):1074-82. Review.

PMID:
3315479

Supplemental Content

Support Center